Skip to main content
55°
Clear
Site search
Search
Menu
Search
Subscribe
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
Contact Us
Subscribe
News
East Greenwich
Kent County Daily Times
Narragansett Times
NK Standard-Times
Sports
Features
Special Sections
Local Guide
Local Events
Markets & Stocks
Weather
League of Women Voters SRI
League of Women Voters WS
Classifieds
Place ad
Business Service Directory
Legal Notices
Place Kent Legal
Place SRI Class Legal
Search SRI Legals
Search Kent Legals
Obituaries
Subscribe
E-Edition
Community Choice
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Biodexa Pharmaceuticals plc - American Depositary Shares
(NQ:
BDRX
)
6.700
UNCHANGED
Streaming Delayed Price
Updated: 3:59 PM EDT, Aug 1, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Biodexa Pharmaceuticals plc - American Depositary Shares
< Previous
1
2
3
4
5
6
7
Next >
Unusual volume stocks in Wednesday's session
February 12, 2025
On Wednesday, there are stocks with unusual volume. Let's take a look.
Via
Chartmill
Following Positive Phase 2 Results and Orphan Drug Designation, Biodexa's FAP Drug Receives FDA Fast Track Status
February 12, 2025
Via
ACCESS Newswire
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
February 11, 2025
Via
Benzinga
Crude Oil Rises Sharply; Manhattan Associates Shares Slide
February 10, 2025
Via
Benzinga
Biodexa Stock Surges On FDA's Fast-Track Tag For Treatment Of Cancer-Causing Condition: Retail Confidence Peaks
February 10, 2025
The drug, a proprietary encapsulated form of rapamycin, is being developed for familial adenomatous polyposis (FAP), a condition that, if left untreated, universally leads to colorectal cancer.
Via
Stocktwits
Biodexa's MX-110 Continues to Show Promise in Recurrent Glioblastoma (rGBM), the Deadliest Brain Cancer
October 17, 2024
Via
ACCESSWIRE
How Is The Market Feeling About Biodexa Pharmaceuticals?
July 16, 2024
Via
Benzinga
Nasdaq Surges 1%; ON Semiconductor Shares Plunge Following Earnings Miss
February 10, 2025
Via
Benzinga
Dow Gains 100 Points; McDonald's Shares Rise After Q4 Results
February 10, 2025
Via
Benzinga
Topics
Stocks
12 Health Care Stocks Moving In Thursday's Pre-Market Session
November 21, 2024
Via
Benzinga
Gaining Momentum, Biodexa is Advancing Two Recent Acquisitions Through the Clinic
November 21, 2024
Via
ACCESSWIRE
BDRX INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation Into Biodexa Pharmaceuticals Plc and Encourages Investors to Contact the Firm
October 28, 2024
From
Bronstein, Gewirtz & Grossman, LLC
Via
Business Wire
BDRX INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation Into Biodexa Pharmaceuticals Plc and Encourages Investors to Contact the Firm
October 20, 2024
From
Bronstein, Gewirtz & Grossman, LLC
Via
Business Wire
12 Health Care Stocks Moving In Thursday's Intraday Session
October 17, 2024
Via
Benzinga
Why Is Brain Cancer-Focused Biodexa Pharmaceuticals Stock Trading Lower On Thursday?
October 17, 2024
Biodexa Pharmaceuticals reports updates from the MAGIC-1 study on MTX110 for recurrent glioblastoma. MTX110 has also demonstrated potential in treating diffuse midline glioma, a rare brain cancer, with...
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
October 17, 2024
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
October 16, 2024
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
October 16, 2024
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
October 16, 2024
Via
Benzinga
Biodexa Pharmaceuticals Stock Is Soaring After The Close: What's Driving Shares Higher?
October 15, 2024
Biodexa Pharmaceuticals shares are soaring in Tuesday's after-hours session after the company announced it was granted an extension to demonstrate compliance with Nasdaq listing requirements.
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
October 15, 2024
Via
Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
September 02, 2024
Via
Benzinga
Why ASP Isotopes Shares Are Trading Lower By 9%? Here Are Other Stocks Moving In Friday's Mid-Day Session
July 12, 2024
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
July 12, 2024
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
Via
InvestorPlace
Why Ericsson Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket
July 12, 2024
Via
Benzinga
Gold Rises Sharply; Methode Electronics Shares Spike Higher
July 11, 2024
Via
Benzinga
Why ConAgra Brands Shares Are Trading Lower? Here Are Other Stocks Moving In Thursday's Mid-Day Session
July 11, 2024
Via
Benzinga
JOBY Stock Pops After Completing 523-Mile eVTOL Flight
July 11, 2024
Joby Aviation stock is flying higher on Thursday after the eVTOL company reported a new milestone for a hydrogen-electric aircraft.
Via
InvestorPlace
Cancer-Focused Nano-Cap Biodexa Pharmaceuticals Stock Is Surging On Thursday - Here's Why
July 11, 2024
Biodexa Pharmaceuticals shares surge following phase 2 trial results for eRapa, a potential treatment for Familial Adenomatous Polyposis. The study showed a 17% median reduction in polyp burden and a...
Via
Benzinga
KZIA Stock Alert: Kazia Continues Its Surge on Thursday With 51% Gains
July 11, 2024
Kazia Therapeutics stock is still rallying on Thursday with heavy trading of KZIA alongside its latest positive clinical trial data.
Via
InvestorPlace
< Previous
1
2
3
4
5
6
7
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.
